Drug-induced liver injury (DILI) and hepatic transporter studies often demand more from an in vitro liver model than short-term metabolic turnover. The cells need to attach reliably, maintain hepatocyte morphology, and - for many transporter workflows - recover the polarity and bile canaliculi architecture that are central to hepatobiliary handling. Plateable primary hepatocytes are designed for this attachment-dependent space, where monolayer, sandwich-culture, and spheroid formats can be selected around the biological question.
For DILI work, this matters because the experimental question may extend beyond a single acute exposure. Plateable hepatocytes are used for hepatotoxicity assessment and hepatic drug metabolism, while sandwich culture supports prolonged hepatic metabolism, drug-drug interaction (DDI) studies, and investigation of mechanisms associated with chronic DILI. For transporter research, the same culture format provides a structured way to examine biliary efflux and uptake transporters in cells that have re-established polarity and bile canaliculi-like networks.
Why Plateable Hepatocytes Fit DILI and Transporter Workflows
Plateable hepatocytes occupy a different experimental niche from hepatocytes used only as a suspended-cell assay. Their value begins with attachment and morphology. In a plateable workflow, cells can be maintained as a monolayer, incorporated into a sandwich culture, or taken into a 3D spheroid format. That flexibility allows the culture system to be matched to the duration and endpoint of the study rather than forcing every experiment into the same format.
Key product characteristics include high post-thaw viability, morphological integrity and attachment efficiency, availability of individual and pooled donor lots, and functional qualification options that include transporter, 3D spheroid, and ASGPR qualification.
| Practical selection principle： Choose the culture format from the endpoint first. For biliary transport and hepatobiliary studies, review transporter qualification and bile canaliculi evidence. For longer-duration or 3D workflows, review spheroid qualification. Then align species, donor configuration, pack size, batch size, and cell specification with the study design. |
Plateable Hepatocytes in DILI Studies
DILI is not a single assay endpoint. Depending on the mechanism under investigation, a study may need to preserve hepatocyte morphology, support continued metabolism, or maintain a culture long enough to observe effects that are difficult to address in a short suspended-cell incubation. Plateable hepatocytes provide an attachment-dependent model for hepatotoxicity assessment, and their compatibility with sandwich culture adds an important option for studies that require prolonged hepatic metabolism or hepatobiliary function.
In sandwich culture, the hepatocyte monolayer is coated with collagen I or Matrigel on both sides. This promotes re-establishment of cellular polarity and the development of bile canaliculi-like networks. That architecture is relevant when DILI questions intersect with transporter function, biliary handling, or DDI mechanisms rather than being limited to general cell injury alone.
For chronic DILI mechanisms in particular, sandwich-cultured hepatocytes provide a model in which prolonged hepatic metabolism and transporter-related processes can be evaluated in the same polarity-restored culture context. The appropriate endpoint still determines the study design: morphology and attachment, transporter behavior, hepatobiliary excretion, metabolic function, and exposure duration should be considered together when selecting a lot and qualification type.
Transporter Studies: Restoring Polarity and Bile Canaliculi
Transporter studies are especially sensitive to cell architecture. Primary hepatocytes in sandwich culture re-establish polarity and form bile canaliculi-like networks, creating a more physiologically structured environment for evaluating biliary efflux and uptake drug transporters. The same format is also used for hepatobiliary excretion studies and can be incorporated into workflows that examine DDI or prolonged metabolism.
A transporter-qualified plateable hepatocyte lot should therefore be evaluated not only for its ability to attach, but also for the functional evidence relevant to the planned assay. Morphology, confluency, bile canaliculi formation, and transporter-associated fluorescent readouts can provide practical confirmation that the culture has reached the intended state before test compounds are interpreted.
Transporter Qualification: SD Rat Sandwich Culture
In an SD rat plateable hepatocyte sandwich-culture example, the cells reached 100% confluency and formed bile canaliculi on day 3. CDFDA staining was taken up into the bile canaliculi, providing a visual transporter-related readout alongside the phase-contrast morphology.
Figure 1. SD rat plateable hepatocytes in sandwich culture demonstrate 100% confluency and bile canaliculi formation on day 3 (A), with CDFDA uptake into bile canaliculi (B).
The practical implication is straightforward: for transporter studies, a plateable hepatocyte lot should be selected with the culture system in mind. If the assay depends on biliary efflux, uptake transporters, or hepatobiliary excretion, transporter qualification and bile canaliculi evidence are more informative than relying on attachment alone.
Where 3D Spheroid-Qualified Hepatocytes Fit
Plateable hepatocytes can also be taken into a 3D spheroid format when the study benefits from an alternative to conventional monolayer culture. Three-dimensional culture is described as maintaining hepatocyte viability while preserving physiologically relevant phenotypes, gene expression, and protein profiles. The format also requires fewer cells, offers technical simplicity, and can be adapted for high-throughput applications.
A cynomolgus monkey hepatocyte example was initiated with 3,000 cells. Over days 4, 6, 7, and 8, the cells progressed into a compact spheroid; after 8 days, the spheroid diameter was approximately 250-300 µm. This qualification provides a concrete reference point for researchers considering 3D plateable-hepatocyte workflows.
Figure 2. Cynomolgus monkey hepatocyte spheroid formation using 3,000 cells. After 8 days of culture, the spheroids were approximately 250-300 µm in diameter.
For a DILI program, spheroid qualification should be viewed as a format option rather than a substitute for transporter qualification. The deciding factor is the study question: sandwich culture directly addresses polarity, bile canaliculi, biliary transporter work, prolonged metabolism, and chronic DILI mechanisms, while spheroid qualification supports a distinct 3D culture workflow.
How to Select Plateable Hepatocytes for a Study
1. Start with the endpoint. Define whether the primary question is hepatotoxicity, biliary transport, uptake or efflux, hepatobiliary excretion, prolonged metabolism, DDI, 3D culture, or another attachment-dependent application.
2. Choose the culture format. Use monolayer culture when attachment-dependent culture is sufficient; consider sandwich culture when polarity and bile canaliculi are important; use 3D spheroid-qualified material when the study is designed around a spheroid format.
3. Match the qualification. For transporter work, prioritize transporter qualification and bile canaliculi evidence. For 3D work, review spheroid qualification. ASGPR qualification is available as a separate functional option when the study requires that receptor-related workflow.
4. Select the biological configuration. The plateable portfolio spans mouse, rat, monkey, dog, feline, rabbit, minipig, hamster, and additional species options. Species, gender, pooled or single-donor configuration, and cell specification can be aligned with the experimental plan.
5. Review lot-specific evidence before scheduling. Attachment, morphology, transporter-related images, spheroid evidence, and other relevant functional characterization should be reviewed alongside pack size, batch size, and inventory requirements.
Quick Reference: Choosing a Plateable Hepatocyte Format
| Study Need | Recommended Format / Qualification | Key Evidence to Review |
| Hepatotoxicity assessment | Plateable hepatocytes | Post-thaw viability, morphology, attachment efficiency, and lot-specific study evidence. |
| Biliary efflux, uptake, or hepatobiliary excretion | Sandwich culture + transporter qualification | Polarity, bile canaliculi formation, confluency, and transporter qualification relevant to the study. |
| Chronic DILI mechanisms / prolonged metabolism | Sandwich-cultured plateable hepatocytes | Culture integrity, prolonged hepatic metabolism context, transporter evidence, and planned exposure design. |
| 3D hepatocyte workflow | 3D spheroid-qualified plateable hepatocytes | Spheroid formation data, culture duration, and lot-specific 3D evidence. |
Plateable Hepatocyte Options at a Glance
| Selection Dimension | Available Options | Why It Matters |
| Culture format | Monolayer, sandwich culture, spheroid | Aligns attachment and culture architecture with the assay endpoint. |
| Functional qualification | Transporter, 3D spheroid, ASGPR | Helps match lot characterization to the planned workflow. |
| Species coverage | Mouse, rat, monkey, dog, feline, rabbit, minipig, hamster, etc. | Supports species-specific study design and translational workflows. |
| Donor configuration | Individual and pooled donor lots | Allows the experimental design to prioritize donor specificity or pooled material. |
| Customization | Gender, species, pack size, batch size, cell specification | Supports project-specific study requirements and logistics. |
| Catalog size shown | 5 million cells | Detailed animal plateable entries in the current portfolio are listed at this size. |
Building a Transporter-Focused Plateable Hepatocyte Workflow
A transporter study is strongest when the biological state of the culture is confirmed before the compound data are interpreted. A practical workflow begins with a plateable, transporter-qualified lot, establishes the sandwich culture under the intended matrix conditions, confirms attachment and confluency, and then checks bile canaliculi formation and the relevant transporter-associated evidence. Only after the culture has reached the intended state should the transport or hepatobiliary endpoint be treated as the central experimental readout.
The SD rat example provides a useful benchmark for what this qualification can look like: day-3 confluency, visible bile canaliculi, and CDFDA uptake into the canalicular network. It is not a universal acceptance criterion for every species or lot, but it illustrates the type of functional evidence that should be matched to a transporter-focused design.
Building a DILI-Focused Plateable Hepatocyte Workflow
For DILI studies, the model should be selected around the mechanism and duration of interest. If the experiment requires attachment-dependent hepatotoxicity assessment, plateable hepatocytes provide the base format. When the question also involves hepatobiliary handling, uptake or efflux transport, DDI, or prolonged hepatic metabolism, sandwich culture becomes particularly relevant because the hepatocytes re-establish polarity and bile canaliculi-like networks.
This distinction helps avoid a common design problem: treating all DILI assays as though they require the same hepatocyte format. A short, metabolism-centered exposure and a chronic, transporter-linked hepatotoxicity question do not impose the same biological requirements. Plateable hepatocytes allow the format and qualification to be selected to fit the mechanism rather than the other way around.
MileCell Primary Plateable Hepatocytes
MileCell provides plateable primary hepatocytes with broad species coverage and flexible options for gender, individual or pooled donor lots, pack size, batch size, and cell specifications. Functional validation options include transporter qualification, 3D spheroid qualification, and ASGPR qualification. The portfolio also lists high post-thaw viability, morphological integrity and attachment efficiency, and inventory availability as core product features.
· Plateable hepatocytes for monolayer, sandwich-culture, and spheroid applications.
· Applications include hepatotoxicity assessment, drug transport, hepatic drug metabolism, and hepatobiliary excretion studies.
· Transporter-qualified material for studies requiring bile canaliculi and biliary transporter-related evidence.
· 3D spheroid-qualified material for spheroid workflows, including the cynomolgus monkey qualification example shown above.
· Flexible species and donor configurations, including pooled and selected single-donor entries in the animal plateable portfolio.
| Next step： Select the study endpoint and culture format first, then request the lot-specific attachment, morphology, transporter, spheroid, or other functional evidence relevant to the experiment. Current availability and configuration options can be confirmed with the MileCell team. |
FAQ: Plateable Hepatocytes for DILI and Transporter Studies
Why use plateable hepatocytes for transporter studies?
Plateable hepatocytes can be used in sandwich culture, where collagen I or Matrigel is applied on both sides of the hepatocyte monolayer. This supports re-establishment of polarity and bile canaliculi-like networks for biliary efflux and uptake transporter studies.
What does the SD rat transporter qualification show?
The SD rat plateable hepatocyte example reached 100% confluency and formed bile canaliculi on day 3. CDFDA staining was taken up into the bile canaliculi.
How are plateable hepatocytes used in DILI research?
Plateable hepatocytes are used for hepatotoxicity assessment. In sandwich culture, they also support prolonged hepatic metabolism, DDI studies, and investigation of mechanisms associated with chronic DILI.
What is the role of 3D spheroid-qualified plateable hepatocytes?
Three-dimensional culture maintains hepatocyte viability while preserving physiologically relevant phenotypes, gene expression, and protein profiles. In the cynomolgus monkey example, 3,000 cells formed spheroids of approximately 250-300 µm after 8 days.
Which species are available for plateable hepatocyte workflows?
The plateable portfolio covers mouse, rat, monkey, dog, feline, rabbit, minipig, hamster, and additional species options. The appropriate species and configuration should be selected around the study design.
Can plateable hepatocyte configurations be customized?
Options include gender, species, pack size, batch size, and cell specification, with individual and pooled donor lots available depending on the product configuration.
Conclusion
Plateable hepatocytes are most useful when the study needs more than a short suspended-cell endpoint. Their ability to support attachment-dependent culture, sandwich-culture polarity, bile canaliculi formation, transporter qualification, and 3D spheroid workflows makes them a practical platform for DILI and transporter research.
For transporter studies, the key is to match the lot to bile canaliculi and transporter-related functional evidence. For DILI studies, the culture format should be chosen around the mechanism and duration of interest, particularly when prolonged metabolism, DDI, or hepatobiliary function is part of the question. Species, donor configuration, qualification type, and lot-specific data can then be aligned with the experimental plan.
Looking for plateable hepatocytes for DILI or transporter studies? Explore MileCell Primary Hepatocytes, request current product information or lot-specific data, or contact the MileCell team for availability and technical support.
Contact: mailto:Info@milecell-bio.com | Website: www.milecell-bio.com
